Results from a phase IIa randomized, double-blind, placebo-controlled, exploratory, multicentre study of GBR 830 in adults with moderate-to-severe atopic dermatitis

Authors
Category Primary study
ConferenceBritish Journal of Dermatology
Year 2018
This article has no abstract
Epistemonikos ID: 9f76375de6bf1144fbef025473f410eb3d9bf895
First added on: Apr 29, 2026